Watch List: KLA-Tencor Corporation (NASDAQ:KLAC) , Ophthotech Corporation (NASDAQ:OPHT)

On 4/6/2017, Shares of KLA-Tencor Corporation (NASDAQ:KLAC) closed at $96.17 in last trading day. After noting the initial trading entry at $95.73, it reached to a day’s high of $96.19 and moved to a day’s low of $94.88. The recent daily volume was 980.73 thousand as contrast to it’s an average volume of 1.12 million.

Technical Indicators:

The last close of the KLA-Tencor Corporation stock reflects that it traded up +3.40% from its 50-day moving average of $93.01. The stock traded above +17.77% to its 200-day MA of $81.66. Furthermore, it moved lower -1.35% from its 52-week high of $97.49 and +43.79% up from $66.88, which is 52-week low of the stock.

KLA-Tencor Corporation’s (KLAC) moved with shift of 0.55% in the past week. Over the last three months, the shares of the company have changed 23.40% and performed 36.88% over the last six months. The stock currently has Monthly Volatility of 1.40% and Weekly Volatility of 1.53%.

KLA-Tencor Corporation designs, manufactures, and markets process control and yield management solutions worldwide. It offers chip manufacturing products, such as front-end defect inspection tools, defect review systems, advanced packaging process control systems, metrology solutions, in-situ process monitoring products, and lithography software; wafer manufacturing products comprising surface and defect inspection, wafer geometry and nanotopography metrology, and data management; and reticle manufacturing products, such as defect inspection and pattern placement metrology products. The company also provides light emitting diode (LED), power device, and compound semiconductor manufacturing products consisting of patterned wafer inspection, defect inspection, surface metrology, and data management products; thin-film head metrology and inspection, virtual lithography, in-situ process monitoring, transparent and metal substrate inspection, and data management products for data storage media/head manufacturing; and stylus and optical profiling, and optical inspection products for microelectromechanical systems manufacturing, as well as products for general purpose/lab applications. It offers its products and services for bare wafer, IC, lithography reticle, and disk manufacturers. The company serves semiconductor and related nanoelectronics, LED, and data storage industries, as well as general materials research industries. KLA-Tencor Corporation was founded in 1975 and is headquartered in Milpitas, California.

Ophthotech Corporation (NASDAQ:OPHT) finalized the last transaction at value of $3.18. The company maintained volume of 932.23 thousand shares. In past trading day, the stock hit the maximum price of $3.22 and touched to minimum value of $3.05. It has a market cap of $ 113.87M.

Technical Indicators:

As of last trade close, the stock is trading  downside -95.18% from its one year high of $65.96 and moved +4.26% upward from $3.05, which is one year low of the stock.

The stock traded below -14.31% from its 50-day moving average of $3.71. Furthermore, the stock moved -83.69% to its 200-day MA of $ 19.50.

During the last month, Ophthotech Corporation’s (OPHT) has changed -12.15% and performed -92.98% over the last 6 months. The mean rating score for this stock is at 3.00. This rating scale contains from 1 to 5 with 5 representing a Strong Sell, 1 signifying a Strong Buy and 3 demonstrating a Hold. The Volatility was noted at 5.54% in recent month and observed Weekly Volatility of 6.17%.

Ophthotech Corporation, a biopharmaceutical company, develops novel therapeutics to treat diseases of the back of the eye. Its principal product candidate, Fovista, an anti-platelet derived growth factor, is in Phase III clinical development for use in combination with anti-vascular endothelial growth factor drugs for the treatment of wet age-related macular degeneration (AMD). The company is also developing Zimura, an inhibitor of complement factor C5, for the treatment of dry AMD and wet AMD. Ophthotech Corporation was founded in 2007 and is headquartered in New York, New York.


Leave a Reply

Your email address will not be published. Required fields are marked *